Palbociclib, also known as PD0332991, is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity.
Molecular Weight:
447.5
Purity:
99% (HPLC)
CAS Number:
[571190-30-2]
Formula:
C24H29N7O2
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted